Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins

J Am Acad Dermatol. 2013 Jul;69(1):e26-7. doi: 10.1016/j.jaad.2012.12.967.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / drug therapy*
  • Desmocollins / immunology
  • Desmocollins / therapeutic use*
  • Head and Neck Neoplasms / complications
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Immunoglobulin G / immunology*
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Pemphigus / complications
  • Pemphigus / diagnosis
  • Pemphigus / drug therapy*
  • Pemphigus / immunology
  • Rituximab
  • Squamous Cell Carcinoma of Head and Neck
  • Tongue Neoplasms / complications
  • Tongue Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Desmocollins
  • Immunoglobulin G
  • Rituximab